Lucid Diagnostics (LUCD) Net Cash Flow (2021 - 2026)
Lucid Diagnostics filings provide 5 years of Net Cash Flow readings, the most recent being -$12.6 million for Q4 2025.
- On a quarterly basis, Net Cash Flow fell 260.55% to -$12.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $12.3 million, a 256.64% increase, with the full-year FY2025 number at $12.3 million, up 256.64% from a year prior.
- Net Cash Flow hit -$12.6 million in Q4 2025 for Lucid Diagnostics, down from $16.2 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $53.6 million in Q4 2021 to a low of -$15.2 million in Q2 2022.
- Median Net Cash Flow over the past 5 years was -$1.1 million (2021), compared with a mean of $1.7 million.
- Biggest five-year swings in Net Cash Flow: tumbled 23804.17% in 2022 and later soared 3806.62% in 2025.
- Lucid Diagnostics' Net Cash Flow stood at $53.6 million in 2021, then tumbled by 108.32% to -$4.5 million in 2022, then fell by 15.56% to -$5.2 million in 2023, then skyrocketed by 252.68% to $7.9 million in 2024, then tumbled by 260.55% to -$12.6 million in 2025.
- The last three reported values for Net Cash Flow were -$12.6 million (Q4 2025), $16.2 million (Q3 2025), and $5.9 million (Q2 2025) per Business Quant data.